Template:Oral hypoglycemics and insulin analogs: Difference between revisions
Content deleted Content added
+Dulaglutide |
m sub--sup |
||
| Line 75: | Line 75: | ||
* [[Albiglutide]]<sup>†</sup> |
* [[Albiglutide]]<sup>†</sup> |
||
* [[Lixisenatide]] |
* [[Lixisenatide]] |
||
* [[Dulaglutide]]< |
* [[Dulaglutide]]<>†</> |
||
| group4 = [[Dipeptidyl peptidase-4 inhibitor|DPP-4 inhibitor]]s |
| group4 = [[Dipeptidyl peptidase-4 inhibitor|DPP-4 inhibitor]]s |
||
Revision as of 12:59, 30 April 2014
This template's initial visibility currently defaults to autocollapse, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.
To change this template's initial visibility, the |state= parameter may be used:
{{Oral hypoglycemics and insulin analogs|state=collapsed}}will show the template collapsed, i.e. hidden apart from its title bar.{{Oral hypoglycemics and insulin analogs|state=expanded}}will show the template expanded, i.e. fully visible.